The Variable Transformation in Metastases from Testicular Germ Cell Tumors: The Need for Selective Biopsy
- 1 July 1981
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 126 (1) , 52-54
- https://doi.org/10.1016/s0022-5347(17)54375-x
Abstract
The propensity for metastatic testicular teratocarcinoma to undergo differentiation, particularly when associated with successful cancer chemotherapy, means that the histology of residual disease following chemotherapy cannot be assumed without biopsy. Four cases in which biopsy of a metastasis was important in determining the management of the patient are presented. Because of the variable nature of the transformation of metastases in testicular germ cell tumors, particularly after chemotherapy, residual disease will often need further biopsy to establish whether it represents residual malignant disease or benign transformation.This publication has 21 references indexed in Scilit:
- Results of combined chemo-surgical therapy for pulmonary metastases from testicular carcinomaCancer, 1978
- The evolution of mature teratoma from malignant testicular tumorsCancer, 1977
- Epidemiology and Pathology of Tumors of Human TestisPublished by Springer Nature ,1977
- Metastatic Teratocarcinoma Following ChemotherapyChest, 1976
- Combination radical surgery and multiple sequential chemotherapy for the treatment of advanced carcinoma of the testis (stage III)Cancer, 1976
- BENIGN TRANSFORMATION OF TESTICULAR CARCINOMA BY CHEMOTHERAPYThe Lancet, 1975
- Testicular tumors.Epidemiologic, etiologic, and pathologic featuresCancer, 1973
- MATURATION IN HUMAN TUMOURSThe Lancet, 1969
- Completely mature pulmonary metastasis from testicular teratocarcinoma.Case report and review of literatureCancer, 1969
- Testicular Embryonal Carcinoma with Adult Teratomatous MetastasesJournal of Urology, 1964